On the other hand, using the human GDF15 reporter vector, results of reporter assays revealed that rhTGFβ treatments downregulated the reporter activity, while co-treatment with CAPE reversed such effect in bladder carcinoma HT1376 cells (Figure 4D). The gene discussed is GDF15; the disease is urinary bladder carcinoma.